Preclinical characterization and first-in-human, phase I trial of the novel ALK inhibitor dirozalkib in advanced non-small cell lung cancer

European Journal of Cancer 2026

View at publisher
Authors: Xinghao Ai, Renhua Guo, Liang Zhang, Jian Fang, Yiping Zhang, Jianhua Chen, Jun Zhao, Feng Ye, Shumei Wang, Meiqi Shi, Xinwei Zhang, Fang Zhang
+7 more Jiakui Li, Li Wang, Xuejie Guo, Lufan Xu, Xianghui Duan, Yan Hu, Shun Lu
DOI: 10.1016/j.ejca.2026.116221
Cited by: 0
References: 19

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Lung Cancer Research Studies Lung Cancer Diagnosis and Treatment

Publication details

Journal / source
European Journal of Cancer
Volume
235
Pages
116221–116221
Publication date
7 January 2026
Language
EN